NCAPD2 and sarcoma: In the Kaplan-Meier Plotter database, high expression of NCAPD2, NCAPG, NCAPH, and NCAPD3 was correlated with poor overall survival in sarcoma patients (p < 0.05), HR = 2.23 (p = 0.00016), 1.63 (p = 0.015), 1.83 (p = 0.0025), and 1.63 (p = 0.024), respectively (Figure 5A).